TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 199 filers reported holding TG THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $69,781 | -62.5% | 8,347 | +11.4% | 0.00% | -55.6% |
Q2 2023 | $186,151 | +71.7% | 7,494 | +4.0% | 0.01% | +50.0% |
Q1 2023 | $108,408 | +14.1% | 7,208 | -10.2% | 0.01% | +50.0% |
Q4 2022 | $94,983 | +99.8% | 8,029 | 0.0% | 0.00% | +100.0% |
Q3 2022 | $47,532 | +79.3% | 8,029 | +28.7% | 0.00% | +100.0% |
Q2 2022 | $26,516 | -67.7% | 6,239 | -27.7% | 0.00% | -66.7% |
Q1 2022 | $82,033 | -87.7% | 8,626 | -75.4% | 0.00% | -66.7% |
Q4 2021 | $666,311 | -42.9% | 35,069 | 0.0% | 0.01% | -47.1% |
Q3 2021 | $1,167,096 | -13.1% | 35,069 | +1.3% | 0.02% | -10.5% |
Q2 2021 | $1,343,530 | -14.0% | 34,636 | +6.8% | 0.02% | -17.4% |
Q1 2021 | $1,562,740 | -6.6% | 32,422 | +0.8% | 0.02% | -8.0% |
Q4 2020 | $1,673,587 | +94.4% | 32,172 | 0.0% | 0.02% | +66.7% |
Q3 2020 | $860,923 | +48.9% | 32,172 | +8.4% | 0.02% | +50.0% |
Q2 2020 | $578,303 | +112.1% | 29,687 | +7.2% | 0.01% | +66.7% |
Q1 2020 | $272,598 | -4.9% | 27,703 | +7.2% | 0.01% | +20.0% |
Q4 2019 | $286,791 | +87.2% | 25,837 | -5.3% | 0.01% | +66.7% |
Q3 2019 | $153,228 | -17.8% | 27,289 | +26.6% | 0.00% | 0.0% |
Q2 2019 | $186,415 | +30.4% | 21,551 | +21.2% | 0.00% | 0.0% |
Q1 2019 | $142,959 | +74.6% | 17,781 | -11.0% | 0.00% | +50.0% |
Q4 2018 | $81,893 | -26.8% | 19,974 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $111,854 | -100.0% | 19,974 | 0.0% | 0.00% | -50.0% |
Q2 2018 | $262,658,000 | +13.1% | 19,974 | +22.1% | 0.00% | +33.3% |
Q1 2018 | $232,284,000 | +173246.3% | 16,358 | 0.0% | 0.00% | +50.0% |
Q4 2017 | $134,000 | -62.6% | 16,358 | -45.9% | 0.00% | 0.0% |
Q3 2017 | $358,000 | +17.8% | 30,247 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $304,000 | -13.6% | 30,247 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $352,000 | +72.5% | 30,247 | +14.7% | 0.00% | +100.0% |
Q3 2016 | $204,000 | +32.5% | 26,377 | +3.7% | 0.00% | 0.0% |
Q2 2016 | $154,000 | -29.0% | 25,432 | 0.0% | 0.00% | -50.0% |
Q1 2016 | $217,000 | -28.4% | 25,432 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $303,000 | +18.4% | 25,432 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $256,000 | -39.3% | 25,432 | 0.0% | 0.00% | -33.3% |
Q2 2015 | $422,000 | +40.2% | 25,432 | +30.8% | 0.00% | +50.0% |
Q1 2015 | $301,000 | -2.3% | 19,448 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $308,000 | +48.1% | 19,448 | 0.0% | 0.00% | +100.0% |
Q3 2014 | $208,000 | +13.7% | 19,448 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $183,000 | – | 19,448 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 2,813,779 | $33,568,000 | 3.32% |
Opaleye Management Inc. | 300,000 | $3,579,000 | 1.50% |
BRIDGER MANAGEMENT, LLC | 3,068,315 | $36,605,000 | 1.21% |
SECTORAL ASSET MANAGEMENT INC | 1,521,667 | $18,153,000 | 0.77% |
STONERIDGE INVESTMENT PARTNERS LLC | 332,576 | $3,968,000 | 0.53% |
Eventide Asset Management | 537,600 | $6,414,000 | 0.32% |
Baker Brothers Advisors | 2,003,991 | $23,908,000 | 0.20% |
Quantitative Systematic Strategies LLC | 25,270 | $302,000 | 0.08% |
Candriam S.C.A. | 236,200 | $2,818,000 | 0.08% |
COLUMBUS CIRCLE INVESTORS | 705,389 | $8,415,000 | 0.07% |